Delivery of therapeutic AAV9 vectors via cisterna magna to treat neurological disorders. (2022)

First Author: Marchi PM
Attributed to:  Gene Therapy Innovation and Manufacturing Centre (GTIMC) funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.molmed.2021.09.007

PubMed Identifier: 34756547

Publication URI: http://europepmc.org/abstract/MED/34756547

Type: Journal Article/Review

Volume: 28

Parent Publication: Trends in molecular medicine

Issue: 1

ISSN: 1471-4914